Investor Relations

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them.

SEC Filings

Document Details

Form

Filing Date

Aug 3, 2022

Document Date

Jun 25, 2022

Form Description

Quarterly report which provides a continuing view of a company's financial position

Filing Group

Quarterly Filings

Company

Charles River Laboratories International, Inc.

Issuer

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Filing Formats

View HTML

XBRL

XBRL Viewer

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA

EX-101.CAL - XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT

EX-101.DEF - XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT

EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT

EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT

XML - XBRL INSTANCE DOCUMENT

Featured Report

Charles River Corporate Citizenship Report
View PDF
Print PDF